Exacerbation of myasthenia gravis by alendronate-Reference-Cited by-同舟云学术

Exacerbation of myasthenia gravis by alendronate

Published:2014-06-17 Issue:9 Volume:25 Page:2319-2320
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Kesikburun S.,Güzelküçük Ü.,Alay S.,Yavuz F.,Tan A. K.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-014-2768-4.pdf

Reference7 articles.

1. Lewis SJ, Smith PE (2001) Osteoporosis prevention in myasthenia gravis: a reminder. Acta Neurol Scand 103:320–322

2. National guidelines for the prevention and management of corticosteroid induced osteoporosis. Bath: UK osteoporosis consensus group; 1998

3. Bone and Tooth Society (2002) National Osteoporosis Society, Royal College of Physicians. Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. London: RCP

4. Lozsadi DA, Peters G, Sadik HY, Kellett MW, Fox SH, Smith DF (2006) Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clin Neurol Neurosurg 108:157–162

5. Wittbrodt ET (1997) Drugs and myasthenia gravis. An update. Arch Intern Med 157:399–408

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update;Journal of Clinical Medicine;2021-04-06

2. Neuromuscular Diseases and Bone;Frontiers in Endocrinology;2019-11-22

3. Ocular Myasthenia Induced by Rivaroxaban in Patient with Deep Vein Thrombosis;Annals of Vascular Surgery;2018-05

4. Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro;Pharmacological Research;2017-05

5. Platycodin D Inhibits Osteoclastogenesis by Repressing the NFATc1 and MAPK Signaling Pathway;Journal of Cellular Biochemistry;2016-11-28